GSGiulia Smeraldi

Giulia Smeraldi

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Giulia Smeraldi has a total of 15 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Extracellular Vesicles in Pregnancy: From Maternal–Fetal Communication to Environmental Perturbation

    by Federica Affranchi, Noemi Aloi, Ilaria Cosentini, Giulia Smeraldi, Paolo Colombo, Gaspare Drago, Silvia Ruggieri, Valeria Longo

    Pregnancy is a uniquely sensitive moment during which environmental exposures may have profound and long-lasting consequences for maternal health, placental function, and fetal development. A successful pregnancy depends on continuous molecular communication among maternal, placental, and fetal compartments. The disruption of these processes by environmental stressors may increase the risk of pregnancy complications, impaired neurodevelopment, and susceptibility to non-communicable diseases later in life. Pregnant women are exposed to dynamic mixtures of chemical, physical, occupational, behavioral, and social stressors from the air, diet, drinking water, consumer products, and residential or workplace environments. The pregnancy exposome framework integrates these external exposures with internal biological responses, including oxidative stress, inflammation, metabolic dysregulation, epigenetic alterations, and changes in circulating biomolecules. However, the mechanisms through which exposure-related signals are transmitted across the maternal–placental–fetal unit remain incompletely understood. Extracellular vesicles may be a key component of this communication network as they transfer protected molecular cargoes, including proteins, lipids, metabolites, and regulatory nucleic acids. Understanding how environmental exposures modify extracellular vesicle biogenesis, composition, and function may reveal mechanisms linking the pregnancy exposome to placental dysfunction, adverse pregnancy outcomes, fetal programming, and early biomarkers of biological effects. This review examines the role of extracellular vesicles in physiological maternal–fetal communication and critically summarizes current human and experimental evidence on how environmental exposures may affect EV characteristics and function during pregnancy, with particular attention to their potential involvement in placental dysfunction and adverse pregnancy outcomes.

  • Open Access

    Dual Effect of 4-Methylumbelliferone on INS1E Cells: Enhancing Migration and Glucose-Stimulated Insulin Secretion

    by Giorgia Adamo, Daniele Romancino, Paola Gargano, Marta Sarullo, Aldo Nicosia, Sabrina Picciotto, Giulia Smeraldi, Antonella Bongiovanni, Monica Salamone

    Recent studies have demonstrated that the coumarin derivative 4-Methylumbelliferone (4MU) has an antidiabetic effect in rodent models. 4MU is known to decrease the availability of hyaluronan (HA) substrates and inhibit the activity of different HA synthases. Nevertheless, it has been observed that 4MU may also affect cellular metabolism. In this study, we utilize the rat insulinoma beta cell line (INS-1E) cultured in both two-dimensional (2D) and three-dimensional (3D) experimental settings (pseudo islets), as an in vitro model to study beta cell functionality. For the first time, we observed that treating INS1E cells with 4MU results in improved insulin secretion. Additionally, we discovered that 4MU treatment elicited morphological changes from multilayer to monolayer conditions, along with a varied distribution of insulin granules and cell adhesion properties. Notably, we found that insulin secretion is not correlated with HA production. The same result was observed in co-culture experiments involving INS-1E cells and stromal vascular fraction (SVF) from adipose tissue. These experiments aim to investigate the effects of 4MU on beta cells in the context of its potential use in early-stage type 1 diabetes and in enhancing islet transplantation outcomes.